Actinium Pharmaceuticals ... (ATNM)
AMEX: ATNM
· Real-Time Price · USD
1.69
0.04 (2.42%)
At close: Aug 15, 2025, 3:59 PM
1.69
0.00%
After-hours: Aug 15, 2025, 05:56 PM EDT
Actinium Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -41.04M | -45.51M | -38.24M | -40.91M | -42.62M | -46.45M | -48.82M | -50.14M | -46.34M | -38.92M | -33.02M | -30.38M | -27.33M | -24.58M | -24.77M | -23.14M | -22.26M | -21.86M |
Depreciation & Amortization | 815K | 800K | 811K | 806K | 804K | 824K | 790K | 752K | 773K | 744K | 699K | 675K | 587K | 536K | 524K | 507K | 485K | 464K |
Stock-Based Compensation | 11.61M | 12.79M | 5.29M | 5.02M | 4.6M | 4.23M | 3.84M | 3.89M | 3.94M | 3.37M | 2.79M | 2.26M | 1.71M | 1.74M | 1.69M | 1.63M | 1.51M | 1.26M |
Other Working Capital | -618K | -355K | -545K | 1.24M | 2.72M | 1.61M | -3.74M | -7.28M | -8.33M | -7.02M | -2.74M | 1.08M | 901K | 383K | 1.11M | -196K | -340K | -393K |
Other Non-Cash Items | -426K | -426K | -426K | 1.09M | 3.33M | 3.47M | 3.47M | 40.12M | 37.62M | 72.19M | 73.16M | 36.68M | 37.7M | 4.01M | 4.28M | -3.77M | -9.64M | -10.6M |
Deferred Income Tax | n/a | n/a | n/a | -1.52M | -3.33M | -3.47M | -3.47M | -40.12M | -37.62M | -37.48M | -37.48M | -1M | -1.69M | -1.69M | -1.69M | 6.36M | 11.89M | 11.89M |
Change in Working Capital | -1.66M | -923K | -506K | 708K | 3.26M | 1.77M | -3.15M | -2.13M | -590K | 34.16M | 38.17M | 38.81M | 36.53M | 1.3M | 1.69M | -1.06M | -1.21M | -1.26M |
Operating Cash Flow | -30.69M | -33.27M | -33.07M | -34.81M | -33.96M | -39.63M | -47.34M | -47.62M | -42.21M | -652K | 8.64M | 11.37M | 11.5M | -21M | -20.87M | -22.07M | -21.48M | -21.41M |
Capital Expenditures | n/a | n/a | -11K | -11K | -41K | -88K | -153K | -169K | -212K | -435K | -366K | -350K | -345K | -136K | -133K | -378K | -318K | -257K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -11K | -11K | -41K | -88K | -153K | -169K | -212K | -435K | -366K | -350K | -345K | -136K | -133K | -378K | -318K | -257K |
Debt Repayment | -9K | -9K | -9K | -8K | -7K | -5K | -4K | -4K | -6K | -28K | -49K | -70K | -88K | -86K | -85K | -84K | -198K | -311K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -95K | -95K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1K | -2K | -2K |
Other Financial Acitivies | n/a | n/a | 75K | 75K | 75K | 336K | 262K | 262K | 1.84M | 1.58M | 1.58M | 1.58M | n/a | 6K | 6K | 21.86M | 21.86M | 74.02M |
Financial Cash Flow | 4.59M | 14.55M | 29.32M | 30.52M | 28.77M | 28.87M | 14.87M | 18.57M | 17.29M | 23.9M | 23.11M | 19.02M | 23.22M | 20.86M | 35.22M | 56.25M | 50.24M | 87.97M |
Net Cash Flow | -26.1M | -18.72M | -3.77M | -4.31M | -5.24M | -10.86M | -32.62M | -29.22M | -25.14M | 22.81M | 31.39M | 30.04M | 34.37M | -282K | 14.22M | 33.8M | 28.45M | 66.31M |
Free Cash Flow | -30.69M | -33.27M | -33.08M | -34.82M | -34M | -39.72M | -47.49M | -47.79M | -42.42M | -1.09M | 8.28M | 11.02M | 11.15M | -21.14M | -21M | -22.45M | -21.8M | -21.66M |